Compare AOSL & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AOSL | YDES |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Semiconductors | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 940.9M | 894.2M |
| IPO Year | 2010 | N/A |
| Metric | AOSL | YDES |
|---|---|---|
| Price | $20.96 | $11.28 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $23.67 | N/A |
| AVG Volume (30 Days) | ★ 423.5K | 40.2K |
| Earning Date | 02-05-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $685,883,000.00 | $510,360.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 2.92 | ★ 45.76 |
| 52 Week Low | $15.90 | $5.30 |
| 52 Week High | $42.00 | $31.00 |
| Indicator | AOSL | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 41.47 | 43.87 |
| Support Level | $20.04 | $10.81 |
| Resistance Level | $23.39 | $11.80 |
| Average True Range (ATR) | 1.46 | 0.69 |
| MACD | -0.25 | -0.05 |
| Stochastic Oscillator | 58.62 | 24.23 |
Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries. It operates in one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.